Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24

Trial Status

Completed5

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT05030129Phase 2Completed
ERG/5-HTP in Fragile X Syndrome (FXS)
Fragile X Syndrome
PrincipalinvestigatorStart date: 2021-10-07
NCT02920892Phase 2Completed
AFQ056 for Language Learning in Children With FXS
Fragile X Syndrome
PrincipalinvestigatorStart date: 2017-08-17

Research Network

Collaboration Network

13 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

Rush University Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05030129Phase 2PrincipalInvestigator

ERG/5-HTP in Fragile X Syndrome (FXS)

Fragile X Syndrome
Completed
NCT02920892Phase 2PrincipalInvestigator

AFQ056 for Language Learning in Children With FXS

Fragile X Syndrome
Completed
NCT00788073Phase 2PrincipalInvestigator

Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome

Fragile X Syndrome
Completed
NCT00823368PrincipalInvestigator

Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001

Fragile X Syndrome
Completed
NCT02126995Phase 2PrincipalInvestigator

A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome

Fragile X Syndrome
Completed

All 5 trials loaded